305 related articles for article (PubMed ID: 11716626)
1. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.
Dawson S; Willoughby K; Gaskell RM; Wood G; Chalmers WS
J Feline Med Surg; 2001 Mar; 3(1):17-22. PubMed ID: 11716626
[TBL] [Abstract][Full Text] [Related]
2. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
[TBL] [Abstract][Full Text] [Related]
3. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine.
Lappin MR
J Feline Med Surg; 2012 Feb; 14(2):161-4. PubMed ID: 22314095
[TBL] [Abstract][Full Text] [Related]
4. Effects of maternally-derived antibodies on serologic responses to vaccination in kittens.
Digangi BA; Levy JK; Griffin B; Reese MJ; Dingman PA; Tucker SJ; Dubovi EJ
J Feline Med Surg; 2012 Feb; 14(2):118-23. PubMed ID: 22314087
[TBL] [Abstract][Full Text] [Related]
5. Questions efficacy of vaccinating cats at 3-year intervals.
Norsworthy GD
Am J Vet Res; 1999 Aug; 60(8):918-9. PubMed ID: 10451196
[No Abstract] [Full Text] [Related]
6. Questions long-term immunity in cats.
Norsworthy GD
J Am Vet Med Assoc; 1999 Aug; 215(3):316-7. PubMed ID: 10434959
[No Abstract] [Full Text] [Related]
7. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.
Lappin MR; Veir J; Hawley J
J Feline Med Surg; 2009 Feb; 11(2):159-62. PubMed ID: 18782676
[TBL] [Abstract][Full Text] [Related]
8. More on efficacy of vaccinating cats at 3-year intervals.
Ellis JA
Am J Vet Res; 1999 Sep; 60(9):1035-6. PubMed ID: 10490067
[No Abstract] [Full Text] [Related]
9. Prevalence of autoantibodies that bind to kidney tissues in cats and association risk with antibodies to feline viral rhinotracheitis, calicivirus, and panleukopenia.
Songaksorn N; Petsophonsakul W; Pringproa K; Lampang KN; Sthitmatee N; Srifawattana N; Piyarungsri K; Thongkorn K
J Vet Sci; 2021 May; 22(3):e38. PubMed ID: 34056879
[TBL] [Abstract][Full Text] [Related]
10. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
[TBL] [Abstract][Full Text] [Related]
11. Results of molecular diagnostic assays targeting feline herpesvirus-1 and feline calicivirus in adult cats administered modified live vaccines.
Ruch-Gallie RA; Veir JK; Hawley JR; Lappin MR
J Feline Med Surg; 2011 Aug; 13(8):541-5. PubMed ID: 21439879
[TBL] [Abstract][Full Text] [Related]
12. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
[TBL] [Abstract][Full Text] [Related]
13. Reaction rate in cats vaccinated with a new controlled-titer feline panleukopenia-rhinotracheitis-calicivirus-Chlamydia psittaci vaccine.
Starr RM
Cornell Vet; 1993 Oct; 83(4):311-23. PubMed ID: 8306654
[TBL] [Abstract][Full Text] [Related]
14. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
Scott FW; Geissinger CM
Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
[TBL] [Abstract][Full Text] [Related]
15. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1.
Lappin MR; Sebring RW; Porter M; Radecki SJ; Veir J
J Feline Med Surg; 2006 Jun; 8(3):158-63. PubMed ID: 16442823
[TBL] [Abstract][Full Text] [Related]
16. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
Lappin MR; Andrews J; Simpson D; Jensen WA
J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445
[TBL] [Abstract][Full Text] [Related]
17. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of two commercial feline rhinotracheitis-calicivirus-panleukopenia vaccines.
Povey RC
Can Vet J; 1979 Oct; 20(10):253-60. PubMed ID: 232426
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tri-combinant vaccine for feline herpesvirus, calicivirus and panleukopenia virus infections in Japanese native cats.
Yagami K; Furukawa T; Fukui M; Hamada H
Jikken Dobutsu; 1985 Jul; 34(3):287-94. PubMed ID: 2998830
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of serum antibody titers against feline panleukopenia virus, feline herpesvirus 1, and feline calicivirus in cats entering a Florida animal shelter.
DiGangi BA; Levy JK; Griffin B; McGorray SP; Dubovi EJ; Dingman PA; Tucker SJ
J Am Vet Med Assoc; 2012 Nov; 241(10):1320-5. PubMed ID: 23113524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]